BCFS001370-Pitt-Merlin-OUD [Landing Page]

Remote Opioid Use Disorder Research Study

The University of Pittsburgh is conducting a research study to improve improve the treatment of chronic pain in people who are taking buprenorphine or buprenorphine/naloxone (e.g., Suboxone, Subutex, Zubsolv).

Fast Facts

Study Background

Many people who are currently receiving treatment for opioid use problems have chronic pain. Researchers are trying to improve chronic pain treatment.

The research study is testing two different interventions along with usual clinical care:

Pain Self-Management (PSM): an educational program in which individuals with chronic pain work with a trained pain coach and a pain peer to explore strategies to effectively manage the daily problems that arise from chronic pain.
Patient-Oriented Dosing (POD): an alternative dosing of buprenorphine or buprenorphine/naloxone which will be adjusted based on pain levels.

Study Background

Many people who are currently receiving treatment for opioid use problems have chronic pain. Researchers are trying to improve chronic pain treatment.

The research study is testing two different interventions along with usual clinical care:

Pain Self-Management (PSM): an educational program in which individuals with chronic pain work with a trained pain coach and a pain peer to explore strategies to effectively manage the daily problems that arise from chronic pain.
Patient-Oriented Dosing (POD): an alternative dosing of buprenorphine or buprenorphine/naloxone which will be adjusted based on pain levels.

Additional Information

Why is this study being done?

This research study aims to evaluate the effectiveness of PSM and/or POD intervention among individuals with chronic pain and OUD in/on:

reducing pain interference
retention in buprenorphine treatment

Is this study for me?

You may qualify for a study if you meet the following criteria.

Inclusion Criteria:

Ages 18+ and experiencing chronic pain
Diagnosed with opioid use disorder (OUD)
Use a form of buprenorphine or buprenorphine/naloxone taken under the tongue (e.g., Suboxone, Subutex, Zubsolv)
Not prescribed 32mg or more of buprenorphine
Not taking an injectable form of buprenorphine (e.g., Brixadi, Sublocade)
Not taking Naltrexone (e.g., Vivitrol) or Methadone

What will happen if I participate in the study?

The study is being conducted virtually via phone or videoconference. In person visits are available at some locations.

All participants will complete a total 5 outcome assessment visits every 3 months for a period of 1 year. The visits will take place at baseline (first visit), Month 3 (the end of the intervention period), Month 6, Month 9, and Month 12 (the end of the study).

Will I be paid for being in this research study?

Participants will receive up to $350.

Will it cost me anything to participate in this study?

There is no cost for you to participate in our research study.